Related Experiment Video

Updated: Jun 30, 2026

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant
08:52

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant

Published on: May 27, 2011

HSV-tk/GCV gene therapy mediated by EBV-LMP1 for EBV-associated cancer

Yang Lifang1, Tang Min, Ai Midan

  • 1Molecular Biology Research Center, Cancer Research Institute, XiangYa School of Medicine, Central South University, ChangSha, Hunan, 410078, PR China. anglifang99@hotmail.com

Journal of Experimental & Clinical Cancer Research : CR
|September 25, 2008
PubMed
Abstract

Insights

Gene therapy using the herpes simplex virus thymidine kinase/ganciclovir (HSV-tk/GCV) suicide gene system shows promise for treating Epstein-Barr virus (EBV)-associated cancers. This novel approach effectively targets EBV-LMP1 positive cancer cells, inhibiting tumor growth.

Area of Science:

  • Oncology
  • Gene Therapy
  • Virology

Background:

  • Epstein-Barr virus (EBV) is linked to various cancers.
  • Current treatments for EBV-associated cancers have limitations.
  • Gene therapy offers a potential new avenue for treatment.

Purpose of the Study:

  • To assess the feasibility of a gene therapy strategy for EBV-associated cancers.
  • To utilize the herpes simplex virus thymidine kinase/ganciclovir (HSV-tk/GCV) suicide gene system.
  • To leverage the EBV-latent membrane protein 1 (LMP1)-NF-kappaB signaling pathway for targeted gene expression.

Main Methods:

  • Construction of the pVLTR-tk plasmid regulated by EBV-LMP1 via NF-kappaB.
  • Evaluation of pVLTR-tk/GCV cytotoxicity using MTT and clonogenic assays.
  • Assessment of apoptosis and tumor growth inhibition in vitro and in vivo.

Main Results:

  • Transfection of pVLTR-tk increased thymidine kinase (TK) activation in EBV-LMP1 positive cells.
  • GCV treatment significantly reduced cancer cell clonogenicity and survival.
  • A bystander effect was observed, and tumor growth was inhibited in vivo.

Conclusions:

  • The pVLTR-tk/GCV suicide gene system demonstrates efficacy against EBV-LMP1 positive cancer cells.
  • This system shows potential as a targeted gene therapy for EBV-associated malignancies.
  • Further development could lead to novel therapeutic strategies for these cancers.

More Related Videos

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...